ストックスクリーナーアプリを入手
19.76
5.99%
-1.26
アフターアワーズ：
19.76
前日終値:
$21.02
開ける：
$21.19
24時間の取引高:
168.54K
Relative Volume:
0.68
時価総額：
$406.01M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.13%
1か月 パフォーマンス:
+17.34%
6か月 パフォーマンス:
-55.05%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$19.34
$21.63
1週間の範囲:
$17.56
$21.99
52週間の値動き範囲:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
TECX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
19.76 | 406.01M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-21 | 開始されました | Mizuho | Outperform |
| 2024-11-20 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-06-24 | 開始されました | TD Cowen | Buy |
| 2023-12-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-05 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-17 | 開始されました | H.C. Wainwright | Buy |
| 2018-07-16 | 開始されました | Wedbush | Outperform |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Tectonic Therapeutic Inc (TECX) 最新ニュース
Tectonic Therapeutic Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Shares Purchased by Barclays PLC - Defense World
Tectonic Therapeutic Inc expected to post a loss of $1.09 a shareEarnings Preview - TradingView
Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Sold by Wells Fargo & Company MN - Defense World
Geode Capital Management LLC Grows Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
How did Tectonic Therapeutic Inc (TECX) fare last session? - uspostnews.com
Tectonic Announces $185 Million Private Placement - The Globe and Mail
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Mizuho - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Increase in Short Interest - Defense World
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75 - Defense World
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Mizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Tectonic Therapeutic at Outperform - marketscreener.com
Mizuho sets Tectonic stock Outperform with $51 target - Investing.com Australia
Mizuho sets Tectonic stock Outperform with $51 target By Investing.com - Investing.com India
Tectonic Therapeutic Inc (NASDAQ: TECX): Blank Check For Growth? - Stocksregister
Vanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025 - marketscreener.com
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - GlobeNewswire
Major Breakthrough: New Phase 1b Heart Failure Drug Data Promises Key Insights at ESC 2025 - Stock Titan
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing - marketscreener.com
Raymond James Financial Inc. Takes Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Major Investment Alert: Insider Buys Big in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares - Investing.com
Commonwealth Equity Services LLC Takes $231,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Thursday 4/10 Insider Buying Report: TECX, GMS - Nasdaq
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares By Investing.com - Investing.com South Africa
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares - Investing.com Canada
Director’s Bold Move: Massive Stock Sale Shakes Tectonic Therapeutic! - TipRanks
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock By Investing.com - Investing.com South Africa
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock - Investing.com
Tectonic Therapeutic Reports Strong 2024 Financial Results - TipRanks
Charles Schwab Investment Management Inc. Invests $218,000 in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Recommendation of “Buy” from Analysts - The AM Reporter
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Average Price Target from Brokerages - Defense World
Tectonic Therapeutic: Buy Rating Affirmed on Strong Financials and Promising Pipeline - TipRanks
Wells Fargo & Company Lowers Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given New $101.00 Price Target at Wells Fargo & Company - Armenian Reporter
Tectonic Therapeutic Inc. (TECX) reports earnings - Quartz
Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com
Tectonic Therapeutic Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tectonic Therapeutic, Inc. SEC 10-K Report - TradingView
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic's TX45 Trial Achieves 30% Disease Reduction, Extends Runway to 2028 - StockTitan
Tectonic Therapeutic Inc expected to post a loss of $1.39 a shareEarnings Preview - TradingView
Tectonic Therapeutic Inc (TECX) 財務データ
Tectonic Therapeutic Inc (TECX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):